Sareum Holdings (GB:SAR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sareum Holdings PLC, a biotech firm developing treatments for autoimmune disease and cancer, has announced the final issue of new Ordinary Shares to RiverFort Global Opportunities, settling the outstanding balance of the Riverfort Facility. The company will not make further withdrawals or issue more shares under this facility. Following the issue, the total shares in circulation and total voting rights will amount to 106,838,797.
For further insights into GB:SAR stock, check out TipRanks’ Stock Analysis page.
